Anzeige
Mehr »
Donnerstag, 12.02.2026 - Börsentäglich über 12.000 News
Drohnen, Robotik, E-Autos: Diese Hightech-Aktie könnte jetzt zünden
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
729 Leser
Artikel bewerten:
(2)

Veeva Systems: Teva Harmonizes European Pharmacy Sales with Veeva CRM

Top 20 pharmaceutical company implements a single solution to align pharmacy sales across Europe

BARCELONA, Spain, March 16, 2022 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Teva Pharmaceuticals has expanded its use of Veeva solutions with the adoption of Veeva CRM to align pharmacy sales on a single platform in eight countries across Europe, including France, Italy, Spain, Bulgaria, Czech Republic, Slovakia, Hungary, and Poland. Teva, which produces generics and biopharmaceutical medicines, needed an advanced solution to unify pharmacy sales across geographies.

Veeva Systems

Teva previously used multiple legacy systems in different countries. The company harmonized its commercial technology landscape across Europe by deploying pharmacy sales on a single platform. Using Veeva CRM for pharmacy sales has reduced administrative burden for Teva and has enabled its teams to easily share best practices between markets.

"Now that our reps are using Veeva CRM for pharmacy sales, we have reduced the time it takes to negotiate the order, which speeds the processing and gets drugs to pharmacies more quickly," said David Savitt, director and head of field technology for Global Digital Commercial at Teva Pharmaceuticals. "We can now optimize the order price more effectively as discount calculations are already pre-loaded into Veeva CRM, making the complete pharmacy order process from capture to delivery seamless and efficient."

Teva's pharmacy sales teams can now work more effectively with pharmacies using an advanced digital order management system accompanied with key information from Veeva CRM MyInsights. Veeva CRM provides pharmacy field forces with actionable insights at the point of sale, including all activity history such as past orders, invoice status, and negotiation history. This complete view helps pharmacy reps drive successful negotiations critical to the sales process.

"Pharmacies tend to be the first point of interaction for patients looking for help and advice," said Rohan Poole, director of commercial strategy at Veeva. "We are helping pharmacy sales teams streamline the amount of time spent recording calls and orders so that they can focus on building relationships with pharmacists to help them improve the patient experience."

Teva also uses Veeva CRM for engagement with healthcare professionals, which includes use of Veeva CLM, Veeva CRM Approved Email, and Veeva CRM Engage Meeting to deliver personalized interactions with customers. Combined with Teva's use of Veeva Vault PromoMats, the company can inform customer interactions with meaningful, tailored content.

Additional Information

For more on Veeva CRM, visit: veeva.com/eu/CRM Connect with Veeva on LinkedIn: linkedin.com/company/veeva-systems Follow @veeva_eu on Twitter: twitter.com/veeva_eu

About Veeva Systems

Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com/eu.

Contact:



Jeremy Whittaker

Veeva Systems

+49-69-50955486

jeremy.whittaker@veeva.com


Kiran May
Veeva Systems
+44-796-643-2912
kiran.may@veeva.com

Logo - https://mma.prnewswire.com/media/1488285/Veeva_Systems_Logo.jpg

© 2022 PR Newswire
Favoritenwechsel
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.